Iowa Oncology Research Association CCOP
3800 Park Nicollet Blvd
Des Moines, Iowa 50309
(952) 993-1516 http://www.ccopnet.com

Use our guide to learn which trials are right for you!

The Iowa Oncology Research Association (IORA) was established by a group of local physicians in 1978 as a non-profit corporation for the purpose of conducting clinical cancer research and providing state-of-the-art cancer treatment to the citizens of Central Iowa. Over the past several years the IORA has expanded its service area and developed into a multidisciplinary consortium of nine Iowa hospitals, 18 gynecologic, medical, pediatric, radiation, and surgical oncology practices, and 72 physicians providing coverage in 59 of Iowa's 99 counties.

In addition to the operations office in Des Moines, the IORA has four affiliate sites located in Ames, Council Bluffs, Mason City and Ottumwa, and a pediatric component located at the Blank Children's Hospital in Des Moines. The IORA has been a principal member of the North Central Cancer Treatment Group (NCCTG) since 1979 and has secondary Research Base relationships with the Eastern Cooperative Oncology Group (ECOG), the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Gynecology Oncology Group (GOG), the Comprehensive Cancer Center at Wake Forest University (CCCWFU), and the Children's Oncology Group (COG). The IORA also actively participates in other non-member Research Base studies through the Cancer Trials Support Unit (CTSU). At any given time the IORA will have 80 to 100 clinical trials available in the areas of cancer treatment, control and prevention.

Under the leadership of Robert J. Behrens, MD, Principal Investigator, the IORA is staffed by eight clinical research associates in the Des Moines Operations Office, two pediatric clinical research associates at Blank Children's Hospital, three clinical research associates in Ames, two clinical research associates in Mason City, and one clinical research associate each in Council Bluffs and Ottumwa.

We've found
38 trials
at this facility
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 12/6/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Ductal Breast Carcinoma in Situ Clinical Trial
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Status: Enrolling, Phase III
Updated: 11/7/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Status: Enrolling, Phase III
Updated: 12/6/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 2/27/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Status: Enrolling, Phase II
Updated: 9/4/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling, Phase III
Updated: 1/26/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 11/7/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 7/9/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer
Status: Enrolling, Phase II
Updated: 4/9/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
Status: Enrolling, Phase II
Updated: 11/7/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Status: Enrolling, Phase III
Updated: 1/15/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Status: Enrolling, Phase II
Updated: 10/7/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 12/23/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Status: Enrolling
Updated: 11/19/2012
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/18/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 1/14/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 8/14/2012
mi
from
Des Moines, IA
Click here to add this to my saved trials
Lymphoma Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma
Status: Enrolling, Phase I
Updated: 7/18/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Status: Enrolling
Updated: 11/18/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial
Status: Enrolling, Phase
Updated: 4/14/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Status: Enrolling, Phase III
Updated: 11/7/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Status: Enrolling
Updated: 9/4/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 11/5/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 12/6/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 4/16/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Status: Enrolling, Phase II
Updated: 4/4/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Status: Enrolling
Updated: 2/5/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Status: Enrolling, Phase II
Updated: 3/25/2014
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
Status: Enrolling, Phase II
Updated: 8/18/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling, Phase III
Updated: 2/22/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/8/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Musculoskeletal, Oncology Clinical Trial
S1202: Duloxetine Hydrochloride to Treat Muscle, Bone, and Joint Pain in Pts W/Early-Stage Breast Cancer Receiving Hormone Therapy
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Clinical Trial
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Status: Enrolling, Phase III
Updated: 1/28/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma Clinical Trial
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Status: Enrolling, Phase II
Updated: 3/4/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials